首页 > 市场调查报告书 > 医疗设备

病患监测行动医疗

市场调查报告书

商品编码

1352133

全球穿戴式医疗设备市场 - 2023-2030

Global Wearable Medical Devices Market - 2023-2030

出版日期: 2023年09月27日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

穿戴式医疗设备 (WMD) 是设计为直接佩戴在身体上以监测生命征象、记录资料和提供治疗的医疗设备。这些设备变得越来越受欢迎，因为它们提供了一种方便的、非侵入性的方法来追踪健康指标并提供治疗。

医疗保健领域的可穿戴技术正在为多种疾病提供解决方案，包括视力丧失、听力损失和残疾。该行业范围广阔，从科幻小说中的外骨骼技术到无处不在的智慧手錶。

例如，直接贴在皮肤上的电子皮肤贴片被视为下一代穿戴式健康技术。贴片中的感测器包括无线发射器，可为临床医生提供连续的远端资料存取。电子皮肤贴片用于生命征象监测、药物传输、伤口护理和运动检测。

医疗保健提供者可以将电子皮肤贴片用于多种目的，使其成为多功能的可穿戴设备。应用健康科学、健康资讯学、药理学和运动机能学都是使用这些设备的学术途径。这些领域的专业人士可以为电子皮肤贴片技术的开发、实施和分析贡献自己的专业知识，进一步推动其趋势地位。

WMD 通常由设备外壳、感测器和通讯系统组成。设备硬体通常包括用于控制和资料处理的微处理器、用于资料储存的记忆体、电源以及蓝牙和Wi-Fi等通讯技术。大规模杀伤性武器可能还配有额外的感测器，用于监测体温和呼吸频率等生命指标。

此外，这些设备也用于监测各种健康问题，包括心臟病、糖尿病、高血压等。它可以监测心率、血压和呼吸频率等生命体征，监测身体活动和睡眠模式，并提供药物治疗。此外，穿戴式医疗设备的技术进步以及远距病患监护和远距医疗的兴起推动了预测期内对穿戴式医疗设备的需求。

动力学

穿戴式医疗设备的技术进步预计将推动全球穿戴式医疗设备市场的成长

2022 年，Apple 在其新发布的手錶中引入了跌倒侦测技术。系列 8 延续了这一趋势。系列 8 采用跌倒侦测技术来识别人员是否跌倒。

该技术始终处于活动状态，但是，在使用锻炼应用程式时，它在 Series 8 中进行了最佳化。这意味着在附近散步或尝试平衡练习的老年人可以使用运动计划不仅可以追踪他们的心率和步数，还可以确保如果他们跌倒，他们将能够透过手錶获得帮助。

除了跌倒侦测之外，Series 8 还透过车祸侦测来提高其安全功能。这款手錶采用了类似的技术，旨在担心发生严重车辆事故时检查用户。当然，这对所有年龄层的人都很有用，但它为仍在开车的老年人增加了额外的安全保障。

Series 8 还具有按需心电图功能，与单导联心电图相当。阅读资讯可以保存在使用者的健康应用程式中，并在必要时在下次医生咨询时存取和分享。

此外，将 Series 8 与药物应用程式结合可能会使管理复杂的药物计划变得更加容易。当需要服用处方药或非处方药时，应用程式会向使用者的手錶发送讯息。使用者可以记录他们服用的药物，并根据需要在应用程式上调整治疗方案。这是一个有用的工具，可以帮助很多老年人。因此，由于上述因素，预计市场在预测期内将继续成长。

耳部穿戴式装置的增加预计将推动全球穿戴式医疗设备市场的成长

2023 年 6 月 13 日，Stat Health 推出了一款 24/7 的入耳式穿戴式设备，旨在评估头部的血流，初步资金为 510 万美元。 J2 Ventures、BonAngels Venture Partners 和众多天使投资者为该公司提供了启动资金。美国空军也向 Stat Health 提供了赠款支持。

此外，总部位于波士顿的 Stat Health 开发了可穿戴设备，以帮助了解头晕、脑雾、偏头痛、昏厥和站立时疲倦等症状。长期新冠肺炎和姿势性心搏过速症候群 (POTS) 是可能导致这些症状的两种常见情况。它们也可能是肌痛性脑脊髓炎/慢性疲劳症候群 (ME/CFS) 或其他直立性疾病的症状。此外，根据 Stat Health 的说法，这些疾病的症状是由于站立时流向大脑的血液减少所引起的。

该公司在约翰霍普金斯大学对其服务进行了临床测试，并于2023 年3 月在美国心臟病学会杂誌(JACC) 上进行了同行评审。Stat Health 声称已经证明了提前几分钟预测晕厥的能力。因此，由于上述因素，预计市场在预测期内将继续成长。

数位健康领域穿戴式装置面临的挑战预计将阻碍全球穿戴式医疗设备市场的成长

根据国家生物技术资讯中心 2022 年报告，Fitbit资料已被用来检测心率和体温水平上增加的信号——这些可能是 COVID-19 的指标，可以提前发现或仅在出现更具体的症状时发现。

这是可穿戴设备的一个极具潜力的应用，然而，基于可穿戴资料的预测的当前状态存在障碍。高估是指将无问题的情况和异常情况系统地识别或预测为有问题的问题，对穿戴式 COVID-19 检测应用产生重大影响。

此外，根据穿戴式装置的资料，通常很难区分 COVID-19、季节性流感，而标准流感导致心率升高的情况通常可以解释为呼吸道疾病的症状，因此，穿戴式装置错误地识别了检测并预测了COVID-19 感染。因此，由于上述因素，预计市场在预测期内将受到阻碍。

Overview

Wearable Medical Devices (WMDs) are medical devices that are designed to be worn directly on the body to monitor vital signs, record data, and give therapies. These devices are becoming increasingly popular because they provide a handy, non-invasive approach to track health indicators and provide therapies.

Wearable technology in healthcare is providing solutions to a wide range of diseases, including vision loss, hearing loss, and disabilities. The sector is vast, ranging from the science-fiction vibe of exoskeleton technology to the ubiquitousness of smartwatches.

For instance, Electronic skin patches, which stick directly to the skin, are seen as the next generation of wearable health technology. Sensors in the patches include wireless transmitters that provide clinicians with continuous remote data access. Electronic skin patches are utilized for vital sign monitoring, medicine delivery, wound care, and motion detection.

Electronic skin patches can be used by healthcare providers for a variety of purposes, making them a versatile wearable device. Applied health sciences, health informatics, pharmacology, and kinesiology are all academic paths to working with these devices. Professionals from these fields can contribute their expertise to the development, implementation, and analysis of electronic skin patch technology, further driving its trend status.

WMDs are typically made up of device housing, sensors, and communication systems. The device hardware typically includes a microprocessor for control and data processing, memory for data storage, power supply, and communication technologies such as Bluetooth and Wi-Fi. WMDs may additionally have extra sensors for monitoring vital indicators like as temperature and breathing rate.

Moreover, these devices are used to monitor a variety of health issues, including heart disease, diabetes, high blood pressure, and more. It can monitor vital signs such as heart rate, blood pressure, and respiratory rate, monitor physical activity and sleep patterns, and provide medication. Furthermore, the increasing technological advancement in wearable medical devices and the rise of remote patient monitoring and telemedicine have driven the demand for wearable medical devices in the forecast period.

Dynamics

Technological Advancement in Wearable Medical Devices is Expected to Drive Global Wearable Medical Device Market Growth

In 2022, Apple introduced fall detection technology available in their newly announced watches. The tendency is continued in Series 8. Series 8 employs fall detection technology to identify whether or not a person has fallen.

This technology is always active, however, it is optimized in the Series 8 when using the workout app. This implies that seniors who are taking a walk around the neighborhood or trying out balance exercises may use the workout program to not only track their heart rate and steps but also to ensure that if they fall, they will be able to receive assistance through their watch.

In addition to fall detection, the Series 8 improves its safety capabilities by including car crash detection. The watch, which employs similar technology, is intended to check on users when it fears a serious vehicle accident. Of course, this is useful for people of all ages, but it adds an extra layer of security for any senior who is still driving.

The Series 8 also has on-demand ECG functionality, which is comparable to a single-lead electrocardiogram. The reading information can be saved on the user's Health app and accessed and shared at their next physician consultation if necessary.

Furthermore, combining the Series 8 with the Medications app might make it much easier to manage a complicated drug plan. When it is time to take prescriptions or over-the-counter meds, the app will send messages to the user's watch. The user can log that they took the meds and adjust the regimen on the app as needed. It's a useful tool that can help a lot of the elderly. Thus, owing to the above factors, the market is expected to drive over the forecast period.

Increasing Launches of Ear Wearable Devices are Expected to Drive Global Wearable Medical Device Market Growth

On June 13, 2023, Stat Health launched a 24/7 in-ear wearable device meant to assess blood flow to the head, with $5.1 million in preliminary funding. J2 Ventures, BonAngels Venture Partners, and a broad group of angel investors provided startup capital to the company. The US Air Force also provided grant support to Stat Health.

Moreover, Boston-based Stat Health created its wearable to aid in the understanding of symptoms such as dizziness, brain fog, migraines, fainting, and weariness when standing. Long COVID and postural orthostatic tachycardia syndrome (POTS) are two frequent conditions that can cause these symptoms. They may also be symptoms of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) or other orthostatic illnesses. Furthermore, according to Stat Health, the symptoms of these disorders are caused by diminished blood flow to the brain when standing.

The company clinically tested its service at Johns Hopkins, and it was peer-reviewed in the Journal of the American College of Cardiology (JACC) in March 2023. Stat Health claimed to have proven the ability to predict fainting minutes in advance. Thus, owing to the above factors, the market is expected to drive over the forecast period.

Challenges for Wearable Devices in Digital Health are Expected to Hamper the Global Wearable Medical Device Market Growth

According to National Center for Biotechnology Information Report 2022, Fitbit data has been utilized to detect increased signals at the level of heart rate and temperature-these are possible indicators of COVID-19 that can be discovered in advance or only when more specific symptoms appear.

This is a highly potential application of wearables, however, the current state of predictions based on wearable data poses obstacles. Overestimation, a problem in which non-problematic situations and anomalies are systematically recognized or forecasted as problematic, has a significant impact on wearable COVID-19 detection applications.

Furthermore, based on wearable data, it is frequently difficult to distinguish between COVID-19, seasonal influenza, and cases of standard influenza-elevated heart rate can be interpreted as a symptom of respiratory illness in general, and as a result, wearables have incorrectly detected and predicted COVID-19 infections. Thus, owing to the above factors, the market is expected to hamper over the forecast period.

Segment Analysis

The global wearable medical devices market is segmented based on device type, product type, application, end user and region.

Owing to the Convenience and Wearability, Accuracy, and Reliability, Integration with Healthcare Systems, Price, and Affordability, the Product Type Segment Accounted for Approximately 23.25% of the Wearable Medical Devices Market Share

Wearable technology allows consumers to measure fitness levels, track whereabouts using GPS, and read text messages more rapidly. Best of all, most of the technologies that enable this are hands-free and portable, eliminating the need to take our devices out of consumer pockets.

Wearables are linked to smart devices, delivering data to them and allowing consumers to view it later as well as in the moment. This might assist consumers in defining objectives and measuring their progress toward them.

Furthermore, the increasing prevalence of chronic diseases, rising product launches and collaborations by the market players, adoption of smartwatches in sports, and advancement in wearable medical watches are the factors expected to drive over the forecast period.

For instance, on November 20, 2022, Digital health start-up H2o Therapeutics received 510(k) marketing clearance from the U.S. Food and Drug Administration for its prescription mobile app Parky for monitoring Parkinson's Disease. Parky App monitors symptoms such as tremors and dyskinesia in real time via the use of the Apple Watch. It is a tool for sharing meaningful and reliable data between patients and medical professionals regarding the course of the disease.

Similarly, Xplore Lifestyle, a Pune-based patient monitoring service provider, introduced a medical-grade smartwatch for continuous cardiac health monitoring. This watch, which claims to be the world's first medical-grade continuous monitoring system in the shape of a watch, was created in collaboration with the Israeli business CardiacSense.

This medical equipment can distinguish between a Normal Heart Rhythm and an Abnormal/Irregular Heart Rhythm (Arrhythmia), particularly Atrial Fibrillation (Afib). It is manufactured in Israel and costs Rs 1 lakh plus taxes.

Additionally, smartwatch innovation is progressing rapidly, driven by advances in sensors, semiconductors, and AI. For example, some smartwatches now feature optical sensors that continuously measure variations in blood volume and composition using a technology called photoplethysmography (PPG). Algorithms produced and continually improved via machine learning use data from these sensors to provide insights into users' activity levels, stress, heart pattern anomalies, and more. Thus, owing to the above factors, the market segment is expected to hold the largest market share over the forecast period.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022, Owing to the Investing in Wearable Technology, Award Recognition, and Technological Advancement in Wearable Medical Devices in the Region

On May 3, 2023, BioIntelliSense, a continuous health monitoring and clinical intelligence company, has been recognized as the "Best Overall Medical Device Company" for 2023 in the 7th annual MedTech Breakthrough Awards program.

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market, selected BioIntelliSense with its BioButton multi-parameter, medical grade wearable device, and advanced clinical intelligence solutions as the 2023 Best Overall Medical Device Company.

The BioIntelliSense comprehensive portfolio of tech-enabled care solutions makes continuous vital sign monitoring efficient, reliable, and cost-effective from in-hospital to home. Its medical grade acute and post-acute solutions empower clinicians with up to 1,440 high-frequency trending measurements per day, versus episodic manually collected vital signs 4-6 times per day, to enable early detection of clinical patient deterioration.

Coupled with the company's advanced data analytics and AlertWatch clinical intelligence engine, this system enables scalable, continuous in-facility and home patient monitoring at a fraction of the cost relative to manually measured traditional care.

Additionally, on April 28, 2023, the Defense Innovation Unit, also known as DIU, in partnership with the private sector, developed a wearable device that was highly successful during the COVID-19 pandemic in identifying infections.

DOD is extending the RATE initiative, which began with the Defence Threat Reduction Agency in 2020, to new user groups following a successful prototype during COVID-19. The DIU's RATE project employs a technologically advanced, predictive artificial intelligence system that was developed utilizing hospital-acquired data from COVID-19-monitored patients. Thus, owing to the above factors, the North American region is expected to hold the largest market share over the forecast period.

Competitive Landscape

The major global players in the market include Vital Connect, Apple Inc, Fitbit Inc, Philips Electronics, Garmin Ltd, Fossil Group, Google Inc, Covidien, Omron Corp, Proteus, TomTom International BV, Xiaomi Technology Co. Ltd, and Huawei Technologies Co., Ltd among others.

COVID-19 Impact Analysis

Wearable medical devices have gained attention during the COVID-19 pandemic for their potential in healthcare. Wearable technology can be used for the early detection of asymptomatic and pre-symptomatic cases of COVID-19.

As COVID-19 expanded, smartwatches that measure blood oxygen saturation (SpO2) were more commonly available, alerting people with low SpO2-a potentially fatal indication that is difficult to identify on one's own.

More than 10% of smartwatch owners in the United States are now utilizing them to detect COVID-19 symptoms. The pandemic may have even boosted smartwatch sales: 15% of US consumers who own a smartwatch purchased it following the outbreak of COVID-19.

Additionally, Wearable sensors that monitor heart rate, skin temperature, and respiratory rate have shown promise in detecting COVID-19. These sensors can track presymptomatic and asymptomatic infections, aiming to decrease the spread of COVID-19.

Also, Healthcare apps can be used to monitor the spread of COVID-19 and gather vital measurements such as pulse, temperature, and sleep duration from users. For instance, in 2021, the Robert Koch Institute partnered with a healthcare start-up to launch an app named Corona Data Donation that gathers vital measurements from users and analyzes whether they are symptomatic of COVID-19.

In contrast, getting healthcare providers to use wearable devices is challenging as healthcare is a highly regulated industry and is slow to adopt new technologies. The majority of healthcare providers are skeptical about the accuracy and reliability of wearable devices.

Also, poor or over-optimistic accuracy results may undermine the applicability of wearable technology in real-world settings. Thus, owing to the above factors, the pandemic had a moderate impact and is expected to improve gradually over the forecast period.

By Product Type

Diagnostic Devices
- Vital Sign Monitoring Devices
- Sleep Monitoring Devices
- Electrocardiographs Fetal
- Obstetric Devices
- Neuromonitoring Devices
- Other diagnostic devices

Therapeutic devices
- Pain Management Devices
- Rehabilitation Devices
- Respiratory Therapy Devices
- Other Therapeutic Devices

By Product Type

Watch
Headband
Wristband
Ear Wear
Others

By Application

Cardiac health
Obesity control
Diabetes care
Fitness monitoring
Sleep tracking
Others

By End User

Sports and Fitness
Home Healthcare
Remote Patient Monitoring
Hospitals
Others

By Region

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe

South America
- Brazil
- Argentina
- Rest of South America

Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific

Middle East and Africa

Key Developments

On August 3, 2022, GOQii introduced Smart Vital Ultra and GOQii Stream devices targeted at young adults and youth, encouraging them to lead healthy and active lifestyles. GOQii is also launching a feather-light and water-resistant device, GOQii Stream that allows a user to make and receive calls via Bluetooth and a built-in speaker and microphone. It features a dial pad, an option to access recent calls, and sync phone contacts. This upcoming device (GOQii Stream) can be booked at GOQii Webstore and e-commerce platforms like Amazon India and Flipkart.
On December 12, 2022, Frost & Sullivan awarded VitalConnect the 2022 North America New Product Innovation Award based on its latest evaluation of the wearable biosensor business for developing a world-class biosensor that comfortably monitors patients and diagnoses several health concerns. VitalConnect greatly lowered hospital workloads by allowing patients who wish to move freely or can be monitored at home to utilize comfortable, cutting-edge cardiac monitoring equipment with the same efficacy and quality as a hospital or home-based device.
On September 27, 2022, Google Cloud and Fitbit Health Solutions introduced the Device Connect for Fitbit solution, which intends to provide healthcare organizations with a more holistic view of patients outside of clinical settings by utilizing data from wearable devices. Participating health systems will get access to consenting patients' wearable data via the Fitbit Web API, which will allow consumers to select what data they share. The data, which includes temperature, heart rate, oxygen levels, sleep, stress, and activity, is then filtered through a data connection with automated normalization and standardization capabilities for analytics via Google Cloud BigQuery. From there, health systems can create and customize analytics dashboards and artificial intelligence models.

Why Purchase the Report?

To visualize the global wearable medical devices market segmentation based on the device type, product type, application, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of wearable medical devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global wearable medical devices market report would provide approximately 69 tables, 70 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Device Type
3.2. Snippet by Product Type
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological Advancement in Wearable Medical Devices
  - 4.1.1.2. Increasing Launches of Ear Wearable Devices
- 4.1.2. Restraints
  - 4.1.2.1. Challenges for Wearable Devices in Digital Health
- 4.1.3. Opportunity
  - 4.1.3.1. The Growing Startups in Wearable Medical Devices
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. Russia-Ukraine War Analysis

8. By Device Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 8.1.2. Market Attractiveness Index, By Device Type
8.2. Diagnostic Devices*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.2.3. Vital Sign Monitoring Devices
- 8.2.4. Sleep Monitoring Devices
- 8.2.5. Electrocardiographs Fetal
- 8.2.6. Obstetric Devices
- 8.2.7. Neuromonitoring Devices
- 8.2.8. Other diagnostic devices
8.3. Therapeutic Devices
- 8.3.1. Pain Management Devices
- 8.3.2. Rehabilitation Devices
- 8.3.3. Respiratory Therapy Devices
- 8.3.4. Other Therapeutic Devices

9. By Product Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.1.2. Market Attractiveness Index, By Product Type
9.2. Watch*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Headband
9.4. Wristband
9.5. Ear Wear
9.6. Others

10. By Application

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.1.2. Market Attractiveness Index, By Application
10.2. Cardiac health*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Obesity control
10.4. Diabetes care
10.5. Fitness monitoring
10.6. Sleep tracking
10.7. Others

11. By End User

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.1.2. Market Attractiveness Index, By End User
11.2. Sports and Fitness*
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Home Healthcare
11.4. Remote Patient Monitoring
11.5. Hospitals
11.6. Others

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
- 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 12.2.7.1. U.S.
  - 12.2.7.2. Canada
  - 12.2.7.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
- 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 12.3.7.1. Germany
  - 12.3.7.2. U.K.
  - 12.3.7.3. France
  - 12.3.7.4. Italy
  - 12.3.7.5. Spain
  - 12.3.7.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
- 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 12.4.7.1. Brazil
  - 12.4.7.2. Argentina
  - 12.4.7.3. Rest of South America
12.5. Asia Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
- 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 12.5.7.1. China
  - 12.5.7.2. India
  - 12.5.7.3. Japan
  - 12.5.7.4. Australia
  - 12.5.7.5. Rest of Asia Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
- 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Product Benchmarking
13.3. Company Share Analysis
13.4. Key Developments and Strategies

14. Company Profiles

14.1. Vital Connect*
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
14.2. Apple Inc
14.3. Fitbit Inc
14.4. Philips Electronics
14.5. Garmin Ltd
14.6. Fossil Group
14.7. Google Inc
14.8. Covidien
14.9. Omron Corp
14.10. Proteus
14.11. TomTom International BV
14.12. Xiaomi Technology Co. Ltd
14.13. Huawei Technologies Co., Ltd